Rpgs Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.40 M
as on 27-05-2024
- Paid Up Capital ₹ 0.10 M
as on 27-05-2024
- Company Age 3 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
About Rpgs Pharma
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.40 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Chakingal Nair and Rasitha Prasad serve as directors at the Company.
- CIN/LLPIN
U24290KA2021PTC150392
- Company No.
150392
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Aug 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rpgs Pharma?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Chakingal Nair | Director | 05-Aug-2021 | Current |
Rasitha Prasad | Director | 05-Aug-2021 | Current |
Financial Performance of Rpgs Pharma.
Enhance accessibility to Rpgs Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Rpgs Pharma?
Unlock access to Rpgs Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Rpgs Human Resources Consultancy Private LimitedActive 3 years 4 months
Chakingal Nair and Rasitha Prasad are mutual person
- Rpgs Papers Private LimitedActive 5 years 7 months
Chakingal Nair and Rasitha Prasad are mutual person
- Rpgs Retail Private LimitedActive 3 years 2 months
Chakingal Nair and Rasitha Prasad are mutual person
- Kizhekkenchery Grameena Nidhi LimitedActive 2 years 5 months
Chakingal Nair and Rasitha Prasad are mutual person
- Rpgs Software Private LimitedActive 3 years 4 months
Chakingal Nair and Rasitha Prasad are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rpgs Pharma?
Rpgs Pharma has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rpgs Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rpgs Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.